Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Comparative Study Of Folfox6m Plus Sir-Spheres® Microspheres Versus Folfox6m Alone As First Line Treatment In Patients With Nonresectable Liver Metastases From Primary Colorectal Carcinoma

NCT00724503 is registered in ClinicalTrials.gov with Sirtex Medical as lead sponsor.

NCT NCT00724503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00724503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Comparative Study Of Folfox6m Plus Sir-Spheres® Microspheres Versus Folfox6m Alone As First Line Treatment In Patients With Nonresectable Liver Metastases From Primary Colorectal Carcinoma
Lead sponsor
Sirtex Medical
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2006
Completion date
May 31, 2015
Enrollment
530 (actual)
Sites
111

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, colorectal carcinoma, liver metastases